Anemia drug safety debate overblown: doctors
152135
Debate about the safety of a group of anemia drugs widely used in cancer patients should focus on a minority of patients who got the drugs for unapproved uses, doctors said on Sunday.
31437
The recent Vioxx withdrawal and testimony from an FDA insider accusing the agency of failing to protect public health are fueling such heightened concern over drug safety that valuable medicines could be kept from patients, doctors said on Friday.
631592
A report last week tying the Type 2 diabetes pill Avandia to increased risk for heart attack and heart-related deaths prompted a flood of calls to local doctors and Internet postings from patients seeking advice about whether to continue taking the commonly prescribed medication.
305432
Our position is: Greater drug safety needs to be coupled with awareness that some risk is inherent in medicine. When it comes to assurances of drug safety, consumers would be advised to heed George Bernard Shaw&#39;s warning to beware of what they wish for.
453423
U.S. cancer doctors on Thursday plan  to ratchet up pressure on the federal Medicare agency to  reverse new limits on use of anemia drugs made by Amgen Inc.  and Johnson & Johnson.
189562
The Food and Drug Administration warned yesterday that anemia-fighting drugs called erythropoietins, which had $10 billion in U.S. sales last year, are being used so aggressively that they may be harming some patients.
10518
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription
339490
CHICAGO A leading doctor says physicians and patients are obliged to keep a close watch on new prescription drugs for side effects.
696385
NEW YORK - In the wake of Merck&#39;s Vioxx debacle, doctors are scrambling to understand why the drug doubled the risk of heart attacks and strokes--and how to know if other medicines carry similar risks.
329407
Responding to a spate of deaths in clinical trials, the Food and Drug Administration yesterday issued its most severe warning possible for drugs widely used to treat anemia in kidney disease patients and cancer patients undergoing chemotherapy.
238665
Calls for changing the way the government monitors drug safety erupted Friday, as consumer advocates and worried patients zeroed in on testimony that five federally approved medicines posed significant health risks.
516150
A top Food and Drug Administration official said on Thursday she disagrees with an agency scientist&#39;s warning that five drugs on the market have significant safety risks.
212231
Cancer doctors seek to loosen federal restrictions on anemia drugs that carry potentially deadly side effects, saying the tight payment guidelines for treatments made by Amgen and Johnson and Johnson are ultimately bad for patients.
567151
Hundreds of thousands of patients taking three brands of painkillers for arthritis were advised yesterday to see their doctors after new research raised fears of an increased risk of heart attacks and strokes.
726765
Amgen Inc. has added a warning to  its anemia drug, Aranesp, for kidney dialysis and cancer  patients after studies on similar drugs showed higher doses can  cause blood clots and death, the company said a letter released  on Friday.
312273
Too many doctors write prescriptions while under the influence of drug companies. Aggressive prosecution of the worst cases could help mend doctor-patient trust.
122706
By Alice Dembner and Stephen Smith, Globe Staff | December 22, 2004. Doctors urged consumers yesterday not to overreact to the potential heart risks of naproxen, saying they are skeptical about research findings